Opexa Therapeutics, Inc. — Form D

Opexa Therapeutics, Inc. of THE WOODLANDS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-27. The offering totals $4.1M, of which $4.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
David E. JordenDirectorThe Woodlands, TX
Gail J. MaderisDirectorThe Woodlands, TX
Michael S. RichmanDirectorThe Woodlands, TX
Scott B. SeamanDirectorThe Woodlands, TX
Neil K. WarmaDirectorThe Woodlands, TX
Donna R. RillExecutive OfficerThe Woodlands, TX
Jaye L. ThompsonExecutive OfficerThe Woodlands, TX
Neil K. WarmaExecutive OfficerThe Woodlands, TX
Chris SchellingDirectorNewton, MA
Chris SchellingExecutive OfficerNewton, MA
Matthew T SeibtExecutive OfficerNewton, MA
Bernie S PaulExecutive OfficerNewton, MA
John M DunnDirectorNewton, MA
John M KloppExecutive OfficerNewton, MA
Stephen T AselageDirectorNewton, MA
Jason M AmelloDirectorNewton, MA
Jefferson E DavisExecutive OfficerNewton, MA
Adrian S QuartelExecutive OfficerNewton, MA
Michelle T GriffinDirectorNewton, MA
Tanya T HaydenExecutive OfficerNewton, MA
Neil K WarmaDirectorToronto, A6
Neil K WarmaExecutive OfficerToronto, A6
Matthew S SeibtExecutive OfficerNewton, MA
Michelle GriffinDirectorNewton, MA
John S KloppExecutive OfficerNewton, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-12-05D$1.5M$1.5M
2020-07-29D$857K$857K
2013-02-19D$650K$650K
2013-02-19D
2012-11-19D$15.0M
2009-04-27D$2.0M$1.1M

More